E. Johannisson — Endo Lab

nonrandomized-trial 1996

Effect of post-coital contraceptive methods on the endometrium and the menstrual cycle

Acta obstetricia et gynecologica Scandinavica ·doi:10.3109/00016349609065738

STUDY OBJECTIVE: To evaluate the effect of treatment with ethinylesteradiol-levonorgestrel or danazol on ovarian function, gonadotrophin release and endometrial development during the time when a pregnancy may occur following unprotected in…

nonrandomized-trial 1988

The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium

Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a136809

Seventeen healthy women aged 24-45 years with regular menstrual periods, proven fertility and not using steroidal contraceptives or IUD were recruited for the study. The volunteers were followed during one control, one treatment and one fol…

nonrandomized-trial 1985

The effect of a prostaglandin synthetase inhibitor on the hormonal profile and the endometrium in women

American journal of obstetrics and gynecology ·doi:10.1016/0002-9378(85)90304-7

A prostaglandin synthetase inhibitor, naproxen, was given continuously throughout the menstrual cycle at a dose of 250 mg twice daily to 10 healthy fertile women (group 1) and at a dose of 1000 mg per day to eight women in the secretory pha…

nonrandomized-trial 1982

Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate

Contraception ·doi:10.1016/0010-7824(82)90132-9

The pharmacokinetic and pharmacodynamic effects of vaginal devices releasing levonorgestrel (L-NOG) at a constant rate (in vitro release: approximately 20 micrograms/day) were studied in a group of 20 normally menstruating women during a pe…